BofA initiated coverage of Fractyl Health with a Buy rating and $26 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on GUTS:
- Fractyl Health appoints Conaway to board of directors
- Fractyl Health Appoints Samuel Conaway to Its Board of Directors, Bolstering New Product Commercial Expertise During Revita® Pivotal Clinical Trials
- Fractyl Health IPO Debut Raises $110 Million in Capital
- Fractyl Health Overhauls Governance Structure Post-IPO